ALTMAN MICHAEL SETH

Director at Freenome, Inc. · on record since Jun 13, 2024
Chief Business Officer at Freenome, Inc. · on record since Jun 13, 2024
10% owner at Freenome, Inc. · on record since Jun 13, 2024
10% owner at Adagio Medical Holdings, Inc. · on record since Aug 1, 2024
Director at Nautilus Biotechnology, Inc. · on record since Jun 11, 2021
Director at ARYA SCIENCES ACQUISITION CORP. · on record since Oct 5, 2018
Chief Financial Officer at ARYA SCIENCES ACQUISITION CORP. · on record since Oct 5, 2018
Director at Lyra Therapeutics, Inc. · on record since Apr 30, 2020
Director at Cerevel Therapeutics Holdings, Inc. · on record since Jun 9, 2020
Chief Financial Officer at Cerevel Therapeutics Holdings, Inc. · on record since Jun 9, 2020
10% owner at ARYA SCIENCES ACQUISITION CORP. · on record since Aug 11, 2020
Director at ARYA Sciences Acquisition Corp IV · on record since Feb 25, 2021
Chief Financial Officer at ARYA Sciences Acquisition Corp IV · on record since Feb 25, 2021
10% owner at ARYA Sciences Acquisition Corp IV · on record since Feb 25, 2021
Director at ARYA Sciences Acquisition Corp V · on record since Jul 15, 2021
Chief Financial Officer at ARYA Sciences Acquisition Corp V · on record since Jul 15, 2021
10% owner at ARYA Sciences Acquisition Corp V · on record since Jul 15, 2021
Former Dir, Ofc, 10% Ownr at Freenome, Inc. · on record since Jul 22, 2026

Insider trading activity of ALTMAN MICHAEL SETH

Transactions on record: 23; since May 1, 2020

Open-market buys: 0

Open-market sells: 0

Companies traded: 7; last filing Jul 22, 2026

Figures computed from official regulatory filings — .

Companies where ALTMAN MICHAEL SETH has traded

3 tx · $2.9M · Jul 22, 2026
4 tx · $5M · Jul 31, 2024
8 tx · Jun 17, 2024
5 tx · Jun 14, 2024
1 tx · $5M · Jul 15, 2021
1 tx · $5M · Aug 11, 2020
1 tx · $5M · Jun 9, 2020

Track record of ALTMAN MICHAEL SETH

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of ALTMAN MICHAEL SETH

Co-insiders of ALTMAN MICHAEL SETH

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Freenome, Inc.Security delisted	Jul 22, 2026	OtherD (derivative)	-2,066,250	—	n/a (No price was disclosed in the filing)	SEC
Freenome, Inc.Security delisted	Jul 22, 2026	Other	2,066,250	—	n/a (No price was disclosed in the filing)	SEC
ARYA Sciences Acquisition Corp IVListing unverified	Jul 31, 2024	OtherD (derivative)	-2,647,500	—	n/a (No price was disclosed in the filing)	SEC
ARYA Sciences Acquisition Corp IVListing unverified	Jul 31, 2024	Other	-499,000	—	n/a (No price was disclosed in the filing)	SEC
ARYA Sciences Acquisition Corp IVListing unverified	Jul 31, 2024	OtherD (derivative)	-1,000,000	—	n/a (No price was disclosed in the filing)	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 17, 2024	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Lyra Therapeutics, Inc.Listing on record	Jun 14, 2024	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Freenome, Inc.Security delisted	Jun 13, 2024	Award	286,250	10.00 USD	$2.9M	SEC
Lyra Therapeutics, Inc.Listing on record	Jul 5, 2023	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 20, 2023	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Lyra Therapeutics, Inc.Listing on record	Jun 21, 2022	AwardD (derivative)	7,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 17, 2022	AwardD (derivative)	86,467	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ARYA Sciences Acquisition Corp VListing unverified	Jul 15, 2021	Award	499,000	10.00 USD	$5M	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 11, 2021	AwardD (derivative)	44,435	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 11, 2021	Other	-499,000	—	n/a (No price was disclosed in the filing)	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 11, 2021	OtherD (derivative)	-3,647,500	—	n/a (No price was disclosed in the filing)	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 11, 2021	Other	499,000	—	n/a (No price was disclosed in the filing)	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 11, 2021	Other	3,647,500	—	n/a (No price was disclosed in the filing)	SEC
Lyra Therapeutics, Inc.Listing on record	May 28, 2021	AwardD (derivative)	7,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ARYA Sciences Acquisition Corp IVListing unverified	Mar 2, 2021	Award	499,000	10.00 USD	$5M	SEC
ARYA SCIENCES ACQUISITION CORP.Listing unverified	Aug 11, 2020	Other	499,000	10.00 USD	$5M	SEC
Cerevel Therapeutics Holdings, Inc.Listing unverified	Jun 9, 2020	Other	499,000	10.00 USD	$5M	SEC
Lyra Therapeutics, Inc.Listing on record	May 1, 2020	AwardD (derivative)	14,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Freenome, Inc.Security delisted	Jul 22, 2026	OtherD (derivative)	-2,066,250	—	n/a (No price was disclosed in the filing)	SEC
Freenome, Inc.Security delisted	Jul 22, 2026	Other	2,066,250	—	n/a (No price was disclosed in the filing)	SEC
ARYA Sciences Acquisition Corp IVListing unverified	Jul 31, 2024	OtherD (derivative)	-2,647,500	—	n/a (No price was disclosed in the filing)	SEC
ARYA Sciences Acquisition Corp IVListing unverified	Jul 31, 2024	Other	-499,000	—	n/a (No price was disclosed in the filing)	SEC
ARYA Sciences Acquisition Corp IVListing unverified	Jul 31, 2024	OtherD (derivative)	-1,000,000	—	n/a (No price was disclosed in the filing)	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 17, 2024	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Lyra Therapeutics, Inc.Listing on record	Jun 14, 2024	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Freenome, Inc.Security delisted	Jun 13, 2024	Award	286,250	10.00 USD	$2.9M	SEC
Lyra Therapeutics, Inc.Listing on record	Jul 5, 2023	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 20, 2023	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Lyra Therapeutics, Inc.Listing on record	Jun 21, 2022	AwardD (derivative)	7,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 17, 2022	AwardD (derivative)	86,467	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ARYA Sciences Acquisition Corp VListing unverified	Jul 15, 2021	Award	499,000	10.00 USD	$5M	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 11, 2021	AwardD (derivative)	44,435	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 11, 2021	Other	-499,000	—	n/a (No price was disclosed in the filing)	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 11, 2021	OtherD (derivative)	-3,647,500	—	n/a (No price was disclosed in the filing)	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 11, 2021	Other	499,000	—	n/a (No price was disclosed in the filing)	SEC
Nautilus Biotechnology, Inc.Listing on record	Jun 11, 2021	Other	3,647,500	—	n/a (No price was disclosed in the filing)	SEC
Lyra Therapeutics, Inc.Listing on record	May 28, 2021	AwardD (derivative)	7,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ARYA Sciences Acquisition Corp IVListing unverified	Mar 2, 2021	Award	499,000	10.00 USD	$5M	SEC
ARYA SCIENCES ACQUISITION CORP.Listing unverified	Aug 11, 2020	Other	499,000	10.00 USD	$5M	SEC
Cerevel Therapeutics Holdings, Inc.Listing unverified	Jun 9, 2020	Other	499,000	10.00 USD	$5M	SEC
Lyra Therapeutics, Inc.Listing on record	May 1, 2020	AwardD (derivative)	14,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC